Your browser doesn't support javascript.
loading
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
Rodger, Alison J; Cambiano, Valentina; Bruun, Tina; Vernazza, Pietro; Collins, Simon; van Lunzen, Jan; Corbelli, Giulio Maria; Estrada, Vicente; Geretti, Anna Maria; Beloukas, Apostolos; Asboe, David; Viciana, Pompeyo; Gutiérrez, Félix; Clotet, Bonaventura; Pradier, Christian; Gerstoft, Jan; Weber, Rainer; Westling, Katarina; Wandeler, Gilles; Prins, Jan M; Rieger, Armin; Stoeckle, Marcel; Kümmerle, Tim; Bini, Teresa; Ammassari, Adriana; Gilson, Richard; Krznaric, Ivanka; Ristola, Matti; Zangerle, Robert; Handberg, Pia; Antela, Antonio; Allan, Sris; Phillips, Andrew N; Lundgren, Jens.
Afiliação
  • Rodger AJ; Research Department of Infection and Population Health, University College London, London, United Kingdom.
  • Cambiano V; Research Department of Infection and Population Health, University College London, London, United Kingdom.
  • Bruun T; Department of Infectious Diseases/CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Vernazza P; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital, St Gallen, Switzerland.
  • Collins S; HIV i-Base, London, United Kingdom.
  • van Lunzen J; University Medical Center Hamburg-Eppendorf, Hamburg-Eppendorf, Germany.
  • Corbelli GM; European AIDS Treatment Group, Bruxelles, Belgium.
  • Estrada V; Hospital Clinico San Carlos and Universidad Complutense, Madrid, Spain.
  • Geretti AM; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
  • Beloukas A; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
  • Asboe D; Chelsea and Westminster NHS Foundation Trust, London, United Kingdom.
  • Viciana P; Hospital Virgen del Rocío, Sevilla, Spain.
  • Gutiérrez F; Hospital General de Elche & Universidad Miguel Hernández, Alicante, Spain.
  • Clotet B; IrsiCaixa Foundation, UAB, UVIC-UCC, Hospital Universitari "Germans Trias i Pujol," Badalona, Catalonia, Spain.
  • Pradier C; Department of Public Health, Nice University Hospital and EA 6312, University Nice Sophia-Antipolis, France.
  • Gerstoft J; Rigshospitalet, Copenhagen, Denmark.
  • Weber R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Westling K; Unit of Infectious Diseases and Dermatology, Department of Medicine, Karolinska Institutet, and Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Prins JM; Academic Medical Center, Amsterdam, the Netherlands.
  • Rieger A; Medical University of Vienna, Vienna, Austria.
  • Stoeckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Kümmerle T; Department of Internal Medicine 1, University Hospital of Cologne, Cologne, Germany.
  • Bini T; Ospedal San Paolo, Milan, Italy.
  • Ammassari A; Ospedale L. Spallanzani, Roma, Italy.
  • Gilson R; Research Department of Infection and Population Health, University College London, London, United Kingdom.
  • Krznaric I; Praxis Driesener Straße, Berlin, Germany.
  • Ristola M; Helsinki University Central Hospital, Helsinki, Finland.
  • Zangerle R; Medical University Innsbruck, Innsbruck, Austria.
  • Handberg P; Hvidovre Universitets Hospital, Hvidovre, Denamrk.
  • Antela A; Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Allan S; Coventry and Warwickshire Hospital, Coventry, United Kingdom.
  • Phillips AN; Research Department of Infection and Population Health, University College London, London, United Kingdom.
  • Lundgren J; Department of Infectious Diseases/CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
JAMA ; 316(2): 171-81, 2016 Jul 12.
Article em En | MEDLINE | ID: mdl-27404185
ABSTRACT
IMPORTANCE A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through condomless sex with suppressed HIV-1 RNA viral load for both anal and vaginal sex.

OBJECTIVE:

To evaluate the rate of within-couple HIV transmission (heterosexual and men who have sex with men [MSM]) during periods of sex without condoms and when the HIV-positive partner had HIV-1 RNA load less than 200 copies/mL. DESIGN, SETTING, AND

PARTICIPANTS:

The prospective, observational PARTNER (Partners of People on ART-A New Evaluation of the Risks) study was conducted at 75 clinical sites in 14 European countries and enrolled 1166 HIV serodifferent couples (HIV-positive partner taking suppressive ART) who reported condomless sex (September 2010 to May 2014). Eligibility criteria for inclusion of couple-years of follow-up were condomless sex and HIV-1 RNA load less than 200 copies/mL. Anonymized phylogenetic analysis compared couples' HIV-1 polymerase and envelope sequences if an HIV-negative partner became infected to determine phylogenetically linked transmissions. EXPOSURES Condomless sexual activity with an HIV-positive partner taking virally suppressive ART. MAIN OUTCOMES AND

MEASURES:

Risk of within-couple HIV transmission to the HIV-negative partner.

RESULTS:

Among 1166 enrolled couples, 888 (mean age, 42 years [IQR, 35-48]; 548 heterosexual [61.7%] and 340 MSM [38.3%]) provided 1238 eligible couple-years of follow-up (median follow-up, 1.3 years [IQR, 0.8-2.0]). At baseline, couples reported condomless sex for a median of 2 years (IQR, 0.5-6.3). Condomless sex with other partners was reported by 108 HIV-negative MSM (33%) and 21 heterosexuals (4%). During follow-up, couples reported condomless sex a median of 37 times per year (IQR, 15-71), with MSM couples reporting approximately 22,000 condomless sex acts and heterosexuals approximately 36,000. Although 11 HIV-negative partners became HIV-positive (10 MSM; 1 heterosexual; 8 reported condomless sex with other partners), no phylogenetically linked transmissions occurred over eligible couple-years of follow-up, giving a rate of within-couple HIV transmission of zero, with an upper 95% confidence limit of 0.30/100 couple-years of follow-up. The upper 95% confidence limit for condomless anal sex was 0.71 per 100 couple-years of follow-up. CONCLUSIONS AND RELEVANCE Among serodifferent heterosexual and MSM couples in which the HIV-positive partner was using suppressive ART and who reported condomless sex, during median follow-up of 1.3 years per couple, there were no documented cases of within-couple HIV transmission (upper 95% confidence limit, 0.30/100 couple-years of follow-up). Additional longer-term follow-up is necessary to provide more precise estimates of risk.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Sexual / Parceiros Sexuais / Infecções por HIV / HIV-1 / Sexo sem Proteção Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Sexual / Parceiros Sexuais / Infecções por HIV / HIV-1 / Sexo sem Proteção Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article